Effect of ascorbic acid and epidermal growth factor in a rat tibia defect

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Research

Background:

• Bone repair is crucial for restoring structural and functional integrity.
• Noncritical bone defects require effective therapeutic strategies for optimal healing.
• Ascorbic acid (AA) and epidermal growth factor (EGF) are potential agents for bone regeneration.

Purpose of the Study:

• To investigate the effects of single-dose and combined application of AA and EGF on bone defect repair.
• To evaluate the biomechanical recovery of bone defects treated with AA, EGF, or a combination thereof.
• To assess the impact of these agents on the stiffness, resistance, and energy absorption of repaired bone.

Main Methods:

• A noncritical bone defect model was established in the tibias of 24 rats.
• Rats were divided into four groups: intact control, AA treatment, EGF treatment, and combined AA-EGF treatment.
• Biomechanical analysis using a three-point flexion test was performed after 21 days to measure stiffness, resistance, maximum energy, and energy at maximum load.

Main Results:

• Groups treated with EGF (G-3) and combined AA-EGF (G-4) demonstrated recovery of intact tibia strength and stiffness after 3 weeks.
• The energy absorption parameters (maximum energy and energy at maximum load) were not significantly recovered in G-3 and G-4.
• The AA-only group (G-2) showed recovery of stiffness but not other biomechanical properties compared to intact controls.

Conclusions:

• Epidermal growth factor (EGF) and the combination of ascorbic acid with EGF (AA-EGF) significantly enhance bone resistance and stiffness in a rat tibia noncritical bone defect model.
• These findings suggest that EGF-based therapies hold promise for improving bone repair outcomes.
• Further research may explore optimizing treatment protocols and evaluating long-term effects.